Table 3.
Compound | DPPH EC50 (mg/L) |
Direct Antioxidant Activity in SH-SY5Y Cells b | Indirect Antioxidant Activity in SH-SY5Y Cells c |
---|---|---|---|
3a | >200 | In d | 20.58 |
3b | >200 | In | 14.07 |
3c | >200 | - | - |
3d | >200 | - | - |
3e | 30.44 | 29.79 | 35.16 |
3f | >200 | - | - |
3g | 81.51 | - | - |
3h | 131.5 | - | - |
3i | 190.9 | - | - |
3j | >200 | - | - |
3k | 59.00 | - | - |
3l | 138.5 | - | - |
3m | 62.65 | - | - |
Ascorbic acid | 14.92 | - | - |
Trolox | 27.76 | - | - |
a The antioxidant activity is expressed as percentage inhibition of ROS formation induced by t-BOOH in SH-SY5Y cells; b the direct antioxidant activity was evaluated after a simultaneously treatment (30 min) with the compound (10 µM) and t-BOOH (100 μM); c the indirect antioxidant activity was evaluated after a chronic treatment (24 h) with the compound (10 μM) then exposed to t-BOOH (100 μM for 30 min); d In: inactive.